ZOETIS INC (ZOE.DE) Fundamental Analysis & Valuation

FRA:ZOE • US98978V1035

Current stock price

100.64 EUR
-1.02 (-1%)
Last:

This ZOE.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ZOE.DE Profitability Analysis

1.1 Basic Checks

  • ZOE had positive earnings in the past year.
  • ZOE had a positive operating cash flow in the past year.
  • Each year in the past 5 years ZOE has been profitable.
  • Each year in the past 5 years ZOE had a positive operating cash flow.
ZOE.DE Yearly Net Income VS EBIT VS OCF VS FCFZOE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • With an excellent Return On Assets value of 17.28%, ZOE belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • With an excellent Return On Equity value of 80.25%, ZOE belongs to the best of the industry, outperforming 98.08% of the companies in the same industry.
  • ZOE has a better Return On Invested Capital (21.95%) than 88.46% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ZOE is significantly above the industry average of 14.90%.
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROIC 21.95%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ZOE.DE Yearly ROA, ROE, ROICZOE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 28.23%, ZOE belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ZOE has grown nicely.
  • Looking at the Operating Margin, with a value of 38.54%, ZOE belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
  • ZOE's Operating Margin has improved in the last couple of years.
  • ZOE has a Gross Margin (71.89%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of ZOE has remained more or less at the same level.
Industry RankSector Rank
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
ZOE.DE Yearly Profit, Operating, Gross MarginsZOE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ZOE.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ZOE is creating value.
  • ZOE has less shares outstanding than it did 1 year ago.
  • ZOE has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ZOE is higher compared to a year ago.
ZOE.DE Yearly Shares OutstandingZOE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
ZOE.DE Yearly Total Debt VS Total AssetsZOE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 5.40 indicates that ZOE is not in any danger for bankruptcy at the moment.
  • ZOE has a Altman-Z score of 5.40. This is amongst the best in the industry. ZOE outperforms 80.77% of its industry peers.
  • ZOE has a debt to FCF ratio of 3.96. This is a good value and a sign of high solvency as ZOE would need 3.96 years to pay back of all of its debts.
  • ZOE has a Debt to FCF ratio (3.96) which is in line with its industry peers.
  • ZOE has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ZOE (2.71) is worse than 82.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Altman-Z 5.4
ROIC/WACC2.44
WACC9%
ZOE.DE Yearly LT Debt VS Equity VS FCFZOE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 3.03 indicates that ZOE has no problem at all paying its short term obligations.
  • ZOE has a better Current ratio (3.03) than 88.46% of its industry peers.
  • A Quick Ratio of 1.94 indicates that ZOE should not have too much problems paying its short term obligations.
  • ZOE has a Quick ratio of 1.94. This is amongst the best in the industry. ZOE outperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 1.94
ZOE.DE Yearly Current Assets VS Current LiabilitesZOE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ZOE.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.45% over the past year.
  • Measured over the past years, ZOE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.77% on average per year.
  • ZOE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.28%.
  • The Revenue has been growing slightly by 7.24% on average over the past years.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.80% on average over the next years.
  • Based on estimates for the next years, ZOE will show a small growth in Revenue. The Revenue will grow by 5.30% on average per year.
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue Next Year4.92%
Revenue Next 2Y4.86%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZOE.DE Yearly Revenue VS EstimatesZOE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ZOE.DE Yearly EPS VS EstimatesZOE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. ZOE.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.00, ZOE is valued on the expensive side.
  • ZOE's Price/Earnings is on the same level as the industry average.
  • ZOE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.71.
  • With a Price/Forward Earnings ratio of 16.32, ZOE is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ZOE is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, ZOE is valued a bit cheaper.
Industry RankSector Rank
PE 18
Fwd PE 16.32
ZOE.DE Price Earnings VS Forward Price EarningsZOE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZOE is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, ZOE is valued a bit cheaper than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.36
EV/EBITDA 13.42
ZOE.DE Per share dataZOE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • ZOE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ZOE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.76
PEG (5Y)1.67
EPS Next 2Y8.92%
EPS Next 3Y8.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. ZOE.DE Dividend Analysis

5.1 Amount

  • ZOE has a Yearly Dividend Yield of 1.64%.
  • Compared to an average industry Dividend Yield of 1.92, ZOE has a dividend in line with its industry peers.
  • ZOE's Dividend Yield is comparable with the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • On average, the dividend of ZOE grows each year by 20.56%, which is quite nice.
Dividend Growth(5Y)20.56%
Div Incr Years4
Div Non Decr Years4
ZOE.DE Yearly Dividends per shareZOE.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • ZOE pays out 33.26% of its income as dividend. This is a sustainable payout ratio.
  • ZOE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
ZOE.DE Yearly Income VS Free CF VS DividendZOE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
ZOE.DE Dividend Payout.ZOE.DE Dividend Payout, showing the Payout Ratio.ZOE.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ZOE.DE Fundamentals: All Metrics, Ratios and Statistics

ZOETIS INC

FRA:ZOE (3/13/2026, 7:00:00 PM)

100.64

-1.02 (-1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners100.79%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap42.48B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts77.6
Price Target132.04 (31.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend1.77
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-1.58%
PT rev (3m)-9.79%
EPS NQ rev (1m)2.52%
EPS NQ rev (3m)2.83%
EPS NY rev (1m)3.06%
EPS NY rev (3m)3.41%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 18
Fwd PE 16.32
P/S 5.15
P/FCF 21.36
P/OCF 16.79
P/B 14.64
P/tB N/A
EV/EBITDA 13.42
EPS(TTM)5.59
EY5.55%
EPS(NY)6.17
Fwd EY6.13%
FCF(TTM)4.71
FCFY4.68%
OCF(TTM)5.99
OCFY5.96%
SpS19.54
BVpS6.88
TBVpS-0.9
PEG (NY)1.76
PEG (5Y)1.67
Graham Number29.41
Profitability
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROCE 27.58%
ROIC 21.95%
ROICexc 26.6%
ROICexgc 40.59%
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
FCFM 24.12%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Debt/EBITDA 2.19
Cap/Depr 127.52%
Cap/Sales 6.56%
Interest Coverage 13.98
Cash Conversion 70.21%
Profit Quality 85.41%
Current Ratio 3.03
Quick Ratio 1.94
Altman-Z 5.4
F-Score6
WACC9%
ROIC/WACC2.44
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.92%
Revenue Next 2Y4.86%
Revenue Next 3Y4.84%
Revenue Next 5Y5.3%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.93%
EBIT Next 3Y9.75%
EBIT Next 5Y8.5%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%

ZOETIS INC / ZOE.DE Fundamental Analysis FAQ

What is the fundamental rating for ZOE stock?

ChartMill assigns a fundamental rating of 6 / 10 to ZOE.DE.


What is the valuation status for ZOE stock?

ChartMill assigns a valuation rating of 4 / 10 to ZOETIS INC (ZOE.DE). This can be considered as Fairly Valued.


What is the profitability of ZOE stock?

ZOETIS INC (ZOE.DE) has a profitability rating of 8 / 10.


What is the financial health of ZOETIS INC (ZOE.DE) stock?

The financial health rating of ZOETIS INC (ZOE.DE) is 7 / 10.


How sustainable is the dividend of ZOETIS INC (ZOE.DE) stock?

The dividend rating of ZOETIS INC (ZOE.DE) is 4 / 10 and the dividend payout ratio is 33.26%.